Asia Pacific Debt Capital Markets
Associated Orders and Proprietary Orders
Prospective investors who are the directors, employees or major shareholders of the Issuer/Guarantor/Company (or equivalent, the “Issuer”), Barclays Bank PLC or our group companies will be considered as having an association with the Issuer, us or our relevant group company. Prospective investors associated with the Issuer or us (including our group companies) should specifically disclose whether they have any such associations to Barclays (and we may be required to pass such information to the Issuer and certain other CMIs) when placing an order for such securities and should disclose, at the same time, if such orders may negatively impact the price discovery process in relation to the offering. Prospective investors who do not disclose their associations are deemed not to be so associated. Where prospective investors disclose such associations but do not disclose that such order may negatively impact the price discovery process in relation to the offering, such order is hereby deemed not to negatively impact the price discovery process in relation to the offering. If a prospective investor is an asset management arm affiliated with Barclays, such prospective investor should indicate when placing an order if it is for a fund or portfolio where Barclays Bank PLC or its group company has more than 50% interest, in which case it will be classified as a “proprietary order” and subject to appropriate handling by Barclays in accordance with the SFC Code and should disclose, at the same time, if such “proprietary order” may negatively impact the price discovery process in relation to the offering. Prospective investors who do not indicate this information when placing an order are hereby deemed to confirm that their order is not such a “proprietary order”. If a prospective investor is otherwise affiliated with Barclays, such that its order may be considered to be a “proprietary order” (pursuant to the SFC Code), such prospective investor should indicate to Barclays when placing such order. Prospective investors who do not indicate this information when placing an order are hereby deemed to confirm that their order is not a “proprietary order”. Where prospective investors disclose such information but do not disclose that such “proprietary order” may negatively impact the price discovery process in relation to the offering, such “proprietary order” is hereby deemed not to negatively impact the price discovery process in relation to the offering.
Order Book Transparency
Prospective investors should ensure, and by placing an order prospective investors are deemed to confirm, that orders placed with Barclays are bona fide, are not inflated and do not constitute duplicated orders (i.e. two or more corresponding or identical orders placed via two or more CMIs). In addition, any other CMIs (including private banks) submitting orders with Barclays should disclose the identities of all investors when submitting orders with us (except for omnibus orders where underlying investor information should be provided to the OCs when submitting orders). When submitting orders with Barclays, private banks should disclose, at the same time, if such order is placed other than on a “principal” basis (whereby it is deploying its own balance sheet for onward selling to investors). Private banks who do not provide such disclosure are hereby deemed to be placing their order on such a “principal” basis. Otherwise, such order may be considered to be an omnibus order (see further below) pursuant to the SFC Code. Private banks should be aware that placing an order on a “principal” basis may require Barclays to categorise it as a proprietary order and apply the “proprietary orders” requirements of the SFC Code to such order and will result in that private bank not being entitled to, and not being paid, any rebate. In the case of omnibus orders submitted to Barclays, CMIs (including private banks) that are subject to the SFC Code should disclose underlying investor information in respect of each order constituting the relevant omnibus order (failure to provide such information may result in that order being rejected). Underlying investor information in relation to omnibus orders should consist of:
· The name of each underlying investor;
· A unique identification number for each investor;
· Whether an underlying investor has any “Associations” (as used in the SFC Code);
· Whether any underlying investor order is a “Proprietary Order” (as used in the SFC Code);
· Whether any underlying investor order is a duplicate order.
In compliance with paragraph 21.3.5(b) of the SFC Code, in sharing such underlying investor information, which may be personal and/or confidential in nature, CMIs (including private banks) agree and warrant (i) to take appropriate steps to safeguard the transmission of such information (including to Barclays, as applicable); and (ii) that they have obtained the necessary consents from the underlying investors for the use, disclosure or transfer of such information (including to Barclays, as applicable). By submitting an order and providing such information (including to Barclays, as applicable) CMIs (including private banks) further warrant that they and the underlying investors have (and are hereby deemed to have) understood and consented to Barclays’ Privacy Notice available at https://www.cib.barclays/content/dam/barclaysmicrosites/ibpublic/documents/gdpr/asia-pacific-privacy-notice.pdf and to the collection, disclosure, use and transfer of such information by Barclays and/or any other third parties as may be required by the SFC Code, and solely for the purpose of complying with the SFC Code, during the bookbuilding process for the offering. Barclays may be asked to demonstrate compliance with its obligations under the SFC Code, and may request other CMIs (including private banks) to provide evidence showing compliance with the obligations above (in particular, that necessary consents have been obtained). In such event, other CMIs (including private banks) are required to provide Barclays with such evidence within three working days. In addition, prospective investors should be aware that certain information may be disclosed by us and other CMIs (including private banks) which is personal and/or confidential in nature to the prospective investor. By placing an order with us or any other CMIs (including private banks), prospective investors are deemed to have understood and consented to Barclays’ Privacy Notice (above) and to the collection, disclosure, use and transfer of such information by Barclays and/or any other third parties as may be required by the SFC Code, and solely for the purpose of complying with the SFC Code, during the bookbuilding process for the offering.
Rebates and Preferential Treatment
The terms and conditions of the relevant offering will be set out in full in the applicable offering document(s), pricing supplement or equivalent document. Prospective investors should be aware that a rebate, including a rebate to private banks for orders they place (other than in relation to securities subscribed by such private banks as principal whereby they are deploying their own balance sheet for onward selling to investors), may be payable upon closing of the offering based on the principal amount of the securities distributed by such private banks to investors. If the applicable offering document(s), pricing supplement or equivalent document discloses any such rebate (including a rebate to private banks), prospective investors should contact their usual Barclays Sales contact for further details, including the details required to be provided to prospective investors pursuant to Paragraph 21.3.7(b) of the SFC Code. CMIs (including private banks) should not offer any rebates to prospective investor clients or pass on any rebates provided by the Issuer to prospective investors nor enter into any arrangements which may result in prospective investors paying different prices for the securities.